CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-29 | KIRK RANDAL J Director | Grant or award · Option to Purchase Common Stock | +25,000 | 25,000 | ||
| 2017-12-29 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,184 | 119,644 | ||
| 2017-12-12 | CANNON JAMES ANTHONY Director | Option exercise | +20,000 | $2.73 | $55K | 387,502 |
| 2017-12-12 | CANNON JAMES ANTHONY Director | Shares withheld for taxes | −13,094 | $4.17 | $55K | 374,408 |
| 2017-12-12 | CANNON JAMES ANTHONY Director | Option exercise · Stock Option (right to buy) | −20,000 | 0 | ||
| 2017-12-11 | Fowler Wyche Director | Option exercise | +20,000 | $2.73 | $55K | 161,870 |
| 2017-12-11 | Fowler Wyche Director | Shares withheld for taxes | −15,800 | $4.20 | $66K | 146,070 |
| 2017-12-11 | Fowler Wyche Director | Option exercise · Stock Option (right to buy) | −20,000 | 0 | ||
| 2017-12-08 | WEISER MICHAEL Director | Option exercise | +20,000 | $2.73 | $55K | 225,370 |
| 2017-12-08 | WEISER MICHAEL Director | Shares withheld for taxes | −12,325 | $4.43 | $55K | 213,045 |
| 2017-12-08 | WEISER MICHAEL Director | Option exercise · Stock Option (right to buy) | −20,000 | 0 | ||
| 2017-11-30 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,172 | 118,460 | ||
| 2017-11-20 | BRENNAN MURRAY Director | Option exercise | +20,000 | $2.73 | $55K | 74,814 |
| 2017-11-20 | BRENNAN MURRAY Director | Shares withheld for taxes | −12,639 | $4.32 | $55K | 62,175 |
| 2017-11-20 | BRENNAN MURRAY Director | Option exercise · Stock Option (right to buy) | −20,000 | 0 | ||
| 2017-11-08 | Cooper Laurence James Neil Chief Executive Officer | Purchase | +6,440 | $4.68 | $30K | 1,083,731 |
| 2017-11-08 | MAUNEY DAVID M MD EVP and Chief Business Officer | Purchase | +4,270 | $4.68 | $20K | 58,662 |
| 2017-10-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,161 | 117,288 | ||
| 2017-09-29 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,149 | 116,127 | ||
| 2017-09-28 | MAUNEY DAVID M MD EVP and Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 |
Page 13 of 16 · 304 trades